Larry Goldstein to Biomarkers
This is a "connection" page, showing publications Larry Goldstein has written about Biomarkers.
Connection Strength
0.467
-
Amylin Dyshomeostasis Hypothesis: Small Vessel-Type Ischemic Stroke in the Setting of Type-2 Diabetes. Stroke. 2021 06; 52(6):e244-e249.
Score: 0.126
-
Vascular Cellular Adhesion Molecule-1 (VCAM-1) and Memory Impairment in African-Americans after Small Vessel-Type Stroke. J Stroke Cerebrovasc Dis. 2020 Apr; 29(4):104646.
Score: 0.115
-
Left atrial enlargement: a cause of stroke? CMAJ. 2011 Jul 12; 183(10):1129-30.
Score: 0.063
-
Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol. J Alzheimers Dis. 2023; 96(2):683-693.
Score: 0.035
-
Homocysteine testing in patients with acute ischemic stroke. Neurology. 2002 Nov 26; 59(10):1541-6.
Score: 0.035
-
Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-ß1-42 and Hypertension. J Alzheimers Dis. 2018; 66(3):1095-1104.
Score: 0.025
-
Association of Osteopontin, Neopterin, and Myeloperoxidase With Stroke Risk in Patients With Prior Stroke or Transient Ischemic Attacks: Results of an Analysis of 13 Biomarkers From the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial. Stroke. 2017 12; 48(12):3223-3231.
Score: 0.025
-
Ischemic Stroke with Troponin Elevation: Patient Characteristics, Resource Utilization, and In-Hospital Outcomes. Cerebrovasc Dis. 2016; 42(3-4):213-23.
Score: 0.022
-
Chronic Systemic Immune Dysfunction in African-Americans with Small Vessel-Type Ischemic Stroke. Transl Stroke Res. 2015 Dec; 6(6):430-6.
Score: 0.021